World Bronchiectasis Day Observed July 1st
World Bronchiectasis Day (July 1) was established in 2022 to raise awareness of bronchiectasis and its increased prevalence in many countries.Â
Tag: global health
All
Latest
All
Latest
Beyfortus Approved in China to Prevent RSV Infants
AstraZeneca and Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) in neonates and infants entering or during their first RSV season.
All
Latest
Enhertu Approved in the EU for Certain NSCLC Patients
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) was approved in the EU as monotherapy for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) whose tumors have an activating HER2 (ERBB2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy.
COVID-19 Death Toll Passes 6,000,000 Worldwide
COVID-19 is responsible for 6,005,755 deaths worldwide and a total of 447,305,940 cases have been documented since the start of the pandemic.
Read MoreGSK and Medicago’s Plant-based Covifenz Vaccine Approved in Canada
Health Canada has approved GlaxoSmithKline and Medicago’s Covifenz COVID-19 vaccine, a plant-based virus-like particles, recombinant, adjuvanted vaccine, for adults age 18-64.
Read More
Cases of Stealth Omicron Subvariant BA.2 Are Increasing
BA.2, a novel subvariant of the Omicron strain of the SARS-CoV-2 virus, is stoking fears of a new wave of COVID-19 infections in the US and internationally.
Read More
Peak Expiratory Flow Device Could Help Improve COPD Diagnoses
The global COPD burden could be significantly reduced in low and middle-income countries by assessing patients via questionnaire and peak expiratory flow device, according to an international study published in JAMA.
Read More
WHO International Classification of Diseases (ICD-11) Goes into Effect
The World Health Organization (WHO) Eleventh Revision of the International Classification of Diseases (ICD-11) has now come into effect, with the latest update going online Feb 11, 2022.
Read More
Canada Authorizes Novavax COVID-19 Vaccine for Adults
Health Canada has granted authorization for Novavax Inc’s COVID-19 vaccine “Nuvaxovid” for adults age 18 and older.
Read More
COVID Mortality Disparities in the UK
The impact of the COVID-19 pandemic hit hardest in deprived areas of England and Wales, with excess years of life lost more than three times as high in the Northwest than the Southwest of England.
Read More
Novavax Vaccine Authorized in Great Britain, New Zealand
Novavax Inc has received authorizations for its COVID-19 vaccine NVX-CoV2373 (brand name Nuvaxovid) in Great Britain and in New Zealand, the company reports.
Read More
ViSi Mobile Continuous Patient Monitoring System Expands in EU
Sotera Wireless will bring its ViSi Mobile patient monitoring technology products to the Netherlands, Belgium, and Luxembourg.
Read More
First Ever World Bronchiectasis Day Scheduled for July 1
Global lung health organizations from the US, Europe, Australia, and Asia have established the first World Bronchiectasis Day for July 1, 2022, to raise awareness of bronchiectasis and its increased prevalence in many countries.Â
Read More
COVID-19 Lethality Increased in Late 2020
A new statistical analysis supports beliefs that COVID-19 became more lethal in the UK in late 2020, while also suggesting that multiple factors—not just the alpha variant of the virus that causes COVID-19—were to blame.
Read More
Traffic-related Pollution Causes 2 Million Pediatric Asthma Cases
Nearly 2 million new cases of pediatric asthma every year may be caused by a traffic-related air pollutant, a problem particularly important in big cities around the world.
Read More